|
⚲
|
| Message |
|---|
| Happy Holidays!! thanks for using AUM13F!! |
| Exome Asset Management LLC
✚
|
|
|---|---|
| CRD # | 304585 |
| SEC # | 801-121896 |
| CIK # | 0002011932 |
| AUM | $210.8 M (2025-03-27) |
| Employees | 10 (60% Investors, 0% Brokers) |
| Phone | 212-403-3900 |
| Address | 330 Madison Avenue New York, NY 10017 |
| Source | [IAPD] [EDGAR] [Website] [LinkedIn] |
| Total AUM ($M) |
|---|
| Sector | Form 13F Holdings | Value ($M) | |
|---|---|---|---|
| Bridgebio Pharma Inc | 6.7 | ||
| Guardant Health Inc | 5.1 | ||
| Geron Corp | 4.8 | ||
| ISIS Pharmaceuticals Inc | 4.8 | ||
| Tenet Healthcare Corp | 4.8 | ||
| Astrazeneca PLC | 3.9 | ||
| UNUM Therapeutics Inc | 3.8 | ||
| Cytokinetics Inc | 3.8 | ||
| Replimune Group Inc | 3.7 | ||
| Lilly Eli & Co | 3.6 | ||
| View All | |||
| Holdings by Sector ($M) |
|---|
| Type | Form D Funds | Date | Sold ($M) | AUM ($M) |
|---|---|---|---|---|
| HF | Emerging Markets Healthcare Partners LLC | [2019-08-28] | 0.0 | 78.8 |
| HF | Worldwide Healthcare Partners LLC | [2019-08-28] | 0.0 | 87.0 |
| AUM Breakdown | Accounts | AUM ($M) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 0 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 6 | 210.8 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 0.0 |
| (n) Other | 0 | 0.0 |
| Total | 6 | 210.8 |
| By Discretionary | ||
| Discretionary | 6 | 210.8 |
| Non-Discretionary | 0 | 0.0 |
| Total | 6 | 210.8 |
| By Non-United States Persons | ||
| Non-United States Persons | 0.0 | |
| United States Persons | 210.8 | |
| Total | 6 | 210.8 |
| Form D Directors | # Filings | # Firms | 2011 - 2025 |
|---|---|---|---|
| Samuel Isaly | 21 |
| EDGAR Form | CIK | 2011 - 2025 |
|---|---|---|
| 13F-HR | [0002011932] |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
LB Partners LLC
✚
|
VA | 0.2 |
|
Brightline Capital Management LLC
✚
|
FL | 0.2 |
|
Caprice Capital Partners LLC
✚
|
CA | 0.2 |
|
Alpha DNA Investment Management LLC
✚
|
MD | 0.2 |
|
Crown Advisors Management Inc
✚
|
CA | 0.2 |
|
Protium Capital Limited
✚
|
0.2 | |
|
GS Gamma Advisors LLC
✚
|
NY | 0.2 |
|
Room40 Capital LLC
✚
|
NY | 0.2 |
|
Westrock Asset Management LLC
✚
|
AR | 0.2 |
|
BRX Global LP
✚
|
CT | 0.2 |